Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
International Journal of Medicinal Mushrooms
Factor de Impacto: 1.423 Factor de Impacto de 5 años: 1.525 SJR: 0.433 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimir: 1521-9437
ISSN En Línea: 1940-4344

Volumen 21, 2019 Volumen 20, 2018 Volumen 19, 2017 Volumen 18, 2016 Volumen 17, 2015 Volumen 16, 2014 Volumen 15, 2013 Volumen 14, 2012 Volumen 13, 2011 Volumen 12, 2010 Volumen 11, 2009 Volumen 10, 2008 Volumen 9, 2007 Volumen 8, 2006 Volumen 7, 2005 Volumen 6, 2004 Volumen 5, 2003 Volumen 4, 2002 Volumen 3, 2001 Volumen 2, 2000 Volumen 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.2018029348
pages 79-88

Shiitake Culinary-Medicinal Mushroom, Lentinus edodes (Agaricomycetes), Supplementation Alters Gut Microbiome and Corrects Dyslipidemia in Rats

Haseeb Anwar
Department of Physiology, Government College University, Faisalabad, Pakistan
Jan S. Suchodolski
Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&M University, College Station, Texas, USA
Muhammad Irfan Ullah
Department of Pathobiology, Faculty of Veterinary Sciences, Bahauddin Zakariya University, Multan, Pakistan
Ghulam Hussain
Department of Physiology, Government College University, Faisalabad, Pakistan
Muhammad Z. Shabbir
Quality Control Laboratory, University of Veterinary and Animal Sciences, Lahore, Pakistan
Imtiaz Mustafa
Department of Physiology, Government College University, Faisalabad, Pakistan
Muhammad U. Sohail
Biomedical Research Center, Qatar University, Qatar


Recent interest in diet-induced modulation of the gut microbiome has led to research on the impact that dietary fibers can have on host health. Lentinus edodes mushroom-derived fibers may act as an appropriate substrate for gut microbe digestion and metabolism. The metabolites that gut microbes excrete can modulate host energy balance, gut absorption, appetite, and lipid metabolism. In the present study, we explored the dynamics of the gut microbiome of hypercholesterolemic rats supplemented with L. edodes. Wistar rats were offered a chow maintenance diet (CMD; CON group) or the same CMD ration with cholesterol (1.5% w/w) and cholic acid (0.5% w/w) added to induce hypercholesterolemia (day 1 to day 24). Hypercholesterolemic rats were subsequently offered either the same cholesterol-cholic acid diet (HC-CON group) or were supplemented with L. edodes (5% w/w; LE group) for 42 days (day 25 to day 66). At the end of the experiment, serum triglycerides, total cholesterol, high-density lipoprotein (HDL) cholesterol, and low-density lipoprotein (LDL) cholesterol concentrations were determined. Colon digesta were subjected to DNA extraction and subsequent 16S rRNA gene sequencing. Raw sequences were quality filtered and statistically analyzed using QIIME and LEfSe tools. Triglyceride concentrations were lower (P = 0.002) in the LE group than in the CON and HC-CON groups. Total cholesterol and LDL cholesterol concentrations were slightly decreased, whereas HDL cholesterol concentrations were increased by L. edodes supplementation compared with the HC-CON group. The gut microbiome of the LE group had higher species richness characterized by increased abundance of Clostridium and Bacteroides spp. Linear discriminant analysis identified bacterial clades that were statistically different among treatment groups. In conclusion, manipulation of gut microbiota through the administration of L. edodes could manage dyslipidemia.

Articles with similar content:

Royal Sun Medicinal Mushroom Agaricus brasiliensis (Higher Basidiomycetes) and the Attenuation of Pulmonary Inflammation Induced by 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone (NNK)
International Journal of Medicinal Mushrooms, Vol.15, 2013, issue 4
Luis Felipe Ribeiro Pinto, Carolina Croccia, Bernardo Tessarollo, Rodolfo Acatauassu Nunes, Marcele Nogueira de Sousa Trotte, Armando Ubirajara Oliveira Sabaa-Srur, Aristofanes Correa Silva, Luiz Carlos Aguiar Vaz, Haroldo Jose de Matos, Agnaldo Jose Lopes
Hypocholesterolemic Effects of the Cauliflower Culinary-Medicinal Mushroom, Sparassis crispa (Higher Basidiomycetes), in Diet-Induced Hypercholesterolemic Rats
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 10
Hyung Joo Suh, Song-Hwan Bae, Sung-Yong Hong, Eun Young Joung, Byung Hee Kim, Yooheon Park, Ki Bae Hong
Safety Evaluation of an Aqueous Extract of Termitomyces robustus (Agaricomycetes) in Wistar Rats
International Journal of Medicinal Mushrooms, Vol.21, 2019, issue 2
Okezie Emmanuel, Victor Chibueze Ude, Ozioma Onyero, Eziuche Amadike Ugbogu, Emmanuel Iroha Akubugwo, Cynthia Ibe, Nduka Ozoji Okomba
Preclinical Assessment of Cardiovascular Alterations Induced by Birch Polypore Mushroom, Piptoporus betulinus (Agaricomycetes)
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 3
James Oluwagbamigbe Fajemiroye, Gustavo Rodrigues Pedrino, Luiz Carlos da Cunha, Aline A. Mourão, Elson Alves Costa, Jordan K. Zjawiony, Jeronimo Raimundo de Oliveira Neto, Stefanne Madalena Marques, Lanussy Porfiro de Oliveira, Abimbola Christanah Elusiyan
Development of an Anti-Atherosclerotic Polyherbal Formulation: GSTC3
Journal of Environmental Pathology, Toxicology and Oncology, Vol.34, 2015, issue 3
Merin Baby, Smitha K. Ramavarma, Achuthan C. Raghavamenon, Jeksy J. Manalil, Jose Padikkala, Indu M. Suseela